References
- Gräßel-Pietrusky R, Hornstein O P. Flow cytometric measurement of ploidy and proliferative activity of carcinomas of the oropharyngeal mucosa. Arch Dermatol Res 1982; 273: 121–8
- Johnson T S, Williamson K D, Cramer M M, Peters L J. Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: Comparison with malignancy grading. Cytometry 1985; 6: 461–70
- Bijman J T, Wagener D JT, Wessels J MC, Broek van den P, Ramaekers F CS. Cell size, DNA, and cytokeratin analysis of human head and neck tumors by flow cytometry. Cytometry 1986; 7: 76–81
- Kaplan A S, Caldarelli D D, Chacho M S, et al. Retrospective DNA analysis of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1986; 112: 1159–62
- Sickle-Santanello B J, Farrar W B, Dobson J L, O'Toole R V, Keyhani-Rofagha S. Flow cytometric analysis of DNA content as a prognostic indicator in squamous cell carcinoma of the tongue. Am J Surg 1986; 152: 393–5
- Feichter G E, Maier H, Adler D, et al. S-phase fractions and DNA-ploidy of oropharyngeal squamous epithelium carcinomas compared with histologic grade, stage, response to chemotherapy and survival. Acta Otolaryngol 1987; 104: 377–84
- Goldsmith M M, Cresson D H, Arnold L A, Postma D S, Askin F B, Pillsbury H C. DNA flow cytometry as a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg 1987; 96: 307–18
- Lampe H B, Flint A, Wolf G T, McClatchey K D. Flow cytometry: DNA analysis of squamous cell carinoma of the upper aerodigestive tract. J Otolaryngol 1987; 16: 371–6
- Kokal W A, Gardine R L, Sheibani K, et al. Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the head and neck region. Am J Surg 1988; 156: 276–80
- Guo Y C, DeSanto L, Osetinsky G V. Prognostic implications of nuclear DNA content in head and neck cancer. Otolaryngol Head Neck Surg 1989; 100: 95–8
- Feichter G E, Mueller A, Kaufman M, et al. Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer. Int J Cancer 1988; 41: 823–8
- Ensley J F, Maciorowski Z, Hassan M, et al. Cellular DNA content parameters in untreated and recurrent squamous cell cancers of the head and neck. Cytometry 1989; 10: 334–8
- Holm L E. Cellular DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis. Laryngoscope 1982; 92: 1064–9
- Goldsmith M M, Cresson D S, Postma D S, Askin F B, Pillsbury H C. Significance of ploidy in laryngeal cancer. Am J Surg 1986; 152: 396–402
- Dyson J ED, Joslin C AF, Quirke P, Rothwell R I, Bird C C. Quantitation by flow cytofluorometry of response of tumours of the uterine cervix to radiotherapy. Br J Radiol 1985; 58: 41–50
- Dyson J ED, Joslin C AF, Rothwell R I, Quirke P, Khoury G G, Bird C C. Flow cytofluorometric evidence for the differential radio-responsiveness of aneuploid and diploid cervix tumours. Radiother Oncol 1987; 8: 263–72
- Franzén G, Olofsson J, Tytor M, Klintenberg C, Risberg B. Preoperative irradiation in oral cavity carcinoma. A study with special reference to DNA pattern, histological response and prognosis. Acta Oncol 1987; 26: 349–55
- Wijkström H, Gustafson H, Tribukait B. Deoxyribonucleic acid analysis in the evaluation of transitional cell carcinoma before cystectomy. J Urol 1984; 132: 894–8
- Peters L J, Brock W A, Chapman J D, Wilson G. Predictive assays of tumor radiocurability. Am J Clin Oncol 1988; 11: 275–87
- Gratzner H G. Monoclonal antibody to 5-bromo- and 5-iododeoxy-uridine: A new reagent for detection of DNA replication. Science 1982; 218: 474–5
- Dolbeare F A, Gratzner H G, Pallavicini M G, Gray J W. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 1983; 80: 5573–7
- Begg A C, McNally N J, Shrieve D C, Kärcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 620–6
- Riccardi A, Danova M, Wilson G, et al. Cell kinetics in human malignancies studied with in vivo adminstration of bromodeoxyuridine and flow cytometry. Cancer Res 1988; 48: 6238–45